Transaction · 0001104659-26-115642
LQDALiquidia Corp
Jeffs Roger
JEFFS ROGER, CEO, reported a transaction classified as exercise at Liquidia Corp involving 13833.000000 shares for an estimated $0.00. Reported holdings after the transaction were 69168.000000 shares. The stored filing text includes a detected 10b5-1 reference.
exerciseSEC transaction code MCEO
- Trade date
- Oct 09, 2026
- Filing date
- Oct 13, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
LQDA price since this filing
Daily closing prices, with the filing date and available return windowsLQDA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +157.8%1w ago +149.5%1d ago +4.5%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001104659-26-115642 Performance Stock Units
- Transaction date
- Oct 09, 2026 Filed Oct 13, 2026, 11:59 PM · 4d delay
- Shares
- 13,833 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 69,168 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership 10b5-1 Detected
Filing-only score
-20 points
Compact filing score computed from stored Form 4 facts. Version v1.
Low filing signal
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
Chief Executive Officer
Officer YesDirector Yes10% NoOther No
Footnotes & amended
- F1
Performance stock units ("PSUs") convert into common stock on a one-for-one basis.
- F2
On January 11, 2024, the Reporting Person was granted 221,338 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vest…
- F3
Includes (i) 18,094 unvested restricted stock units ("RSUs") of the 289,500 RSUs granted to the Reporting Person on January 11, 2023, (ii) 69,168 unvested RSUs of the 221,338 RSUs granted to the Repor…
- F4
On January 11, 2025, the Reporting Person was granted 229,327 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs vest…
- F5
Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
- F6
These shares were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025.
- F7
The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
- F8
The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Se…
Related transactions
Same SEC filing0 other transactions
Recent company activity
LQDA0 recent txs